ELICIO THERAPEUTICS, INC.

Profile

Company Names

ELICIO THERAPEUTICS, INC.
ANGION BIOMEDICA CORP.

Addresses

451 D STREET, 5TH FLOOR, BOSTON, MA 02210

451 D STREET, 5TH FLOOR, BOSTON, MA 02210

456 MONTGOMERY STREET, SUITE 1200, SAN FRANCISCO, CA 94104

51 CHARLES LINDBERGH BOULEVARD, UNIONDALE, NY 11553

Phone Numbers

(857) 209-0050
(415) 655-4899
(516) 326-1200

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$51,998,853.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2024-03-19 
$6,000,000.00 
$6,000,000.00 
$0.00 
 
7
2023-12-22 
$7,047,530.00 
$7,047,530.00 
$0.00 
Equity 
6
2020-06-12 
$6,695,000.00 
$40,000,000.00 
$33,305,000.00 
Equity 
5
2020-01-14 
$1,000,000.00 
$12,000,000.00 
$11,000,000.00 
Equity 
4
2019-12-24 
$6,081,980.00 
$12,000,000.00 
$5,918,020.00 
Debt 
3
2018-07-05 
$15,379,000.00 
$35,000,000.00 
$19,621,000.00 
Equity 
2
2017-01-11 
$5,438,891.00 
$5,438,891.00 
$0.00 
Equity 
1
2015-01-07 
$4,356,452.00 
$15,000,000.00 
$10,643,548.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JULIAN 
 
ADAMS 
DIRECTOR
INFINITY PHARMACEUTICALS, INC.   |  VEDANTRA PHARMACEUTICALS, INC.   |  ELICIO THERAPEUTICS, INC.   |  ELICIO THERAPEUTICS, INC.
CAROL 
 
ASHE 
DIRECTOR
ELICIO THERAPEUTICS, INC.   |  ELICIO THERAPEUTICS, INC.
YEKATERINA 
 
CHUDNOVSKY 
DIRECTOR
ELICIO THERAPEUTICS, INC.   |  ELICIO THERAPEUTICS, INC.   |  IMMIX BIOPHARMA, INC.
ROBERT 
 
CONNELLY 
EXECUTIVE OFFICER, DIRECTOR
PRONUTRIA BIOSCIENCES, INC.   |  PULMATRIX OPERATING COMPANY, INC.   |  CEREHEALTH CORP   |  AXCELLA HEALTH INC.   |  ELICIO THERAPEUTICS, INC.   |  ELICIO THERAPEUTICS, INC.
PETER 
 
DEMUTH 
EXECUTIVE OFFICER
ELICIO THERAPEUTICS, INC.
VICTOR 
 
GANZI 
DIRECTOR
ANGION BIOMEDICA CORP.
ITZHAK 
D. 
GOLDBERG 
EXECUTIVE OFFICER, DIRECTOR
ANGION BIOMEDICA CORP.
CHRISTOPHER 
 
HAQQ 
EXECUTIVE OFFICER
SANTA MARIA BIOTHERAPEUTICS, INC.   |  PINTA BIOTHERAPEUTICS, INC.   |  NINA BIOTHERAPEUTICS, INC.   |  ELICIO THERAPEUTICS, INC.   |  TJB MEDICAL, INC.   |  ELICIO THERAPEUTICS, INC.
ALLEN 
 
NISSENSON 
DIRECTOR
ANGION BIOMEDICA CORP.   |  DIALITY INC   |  ELICIO THERAPEUTICS, INC.
GIL 
 
OMENN 
DIRECTOR
ANGION BIOMEDICA CORP.
BRIAN 
 
PIEKOS 
EXECUTIVE OFFICER
ELICIO THERAPEUTICS, INC.
ROBERT 
 
RUFFOLO 
DIRECTOR
X-VAX TECHNOLOGY, INC.   |  ELICIO THERAPEUTICS, INC.   |  ELUCIDA ONCOLOGY, INC.   |  SAPIENCE THERAPEUTICS, INC.   |  LB PHARMACEUTICALS INC   |  NACUITY PHARMACEUTICALS, INC.   |  SCIFLUOR LIFE SCIENCES, INC.   |  OCUTERRA THERAPEUTICS, INC.   |  ARIDIS PHARMACEUTICALS, INC.   |  ELICIO THERAPEUTICS, INC.
JAY 
 
VENKATESAN 
DIRECTOR, EXECUTIVE OFFICER
LION BIOTECHNOLOGIES, INC.   |  AURASENSE THERAPEUTICS, LLC   |  ONCOTHYREON INC.   |  ALPINE IMMUNE SCIENCES, INC.   |  TRANSPLANT GENOMICS INC.   |  ANGION BIOMEDICA CORP.   |  TIVORSAN PHARMACEUTICALS, INC.   |  ALPINE IMMUNE SCIENCES, INC.   |  ELICIO THERAPEUTICS, INC.
JAY 
R. 
VENKATESAN 
EXECUTIVE OFFICER, DIRECTOR
EXICURE, INC.   |  EXICURE, INC.   |  ANGION BIOMEDICA CORP.
KAREN 
 
WILSON 
DIRECTOR
ANGION BIOMEDICA CORP.   |  ELICIO THERAPEUTICS, INC.
MICHAEL 
 
YAMIN 
DIRECTOR
ANGION BIOMEDICA CORP.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-03-29
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2024-03-19 
2024-01-05
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-12-22 
2020-06-23
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-06-12 
2020-01-27
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-01-14 
2020-01-13
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2019-12-24 
2018-07-17
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-01-11 
2018-07-17
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-07-05 
2015-02-20
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
Equity 
2015-01-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
GP NURMENKARI INC.
153480
NONE
NONE
T.R. WINSTON + COMPANY, LLC
10571
NONE
NONE
H.C. WAINRIGHT + CO., LLC
375
NONE
NONE
T.R. WINSTON + COMPANY, LLC
10571